Course contents
Foundations of Chemical Peeling5 min readUpdated 7 June 2026

Endpoints & Frosting: Reading the Skin

Reading erythema, the levels of frosting (I–III), pseudofrost and other endpoints in real time — and why frosting is an endpoint indicator for some peels, not a measure of efficacy.

Endpoints are the visible signals — erythema, frosting, epidermal sliding — that you read at the chair to titrate a peel in real time and decide when to stop or neutralise. For coagulant peels such as TCA, the frost is a genuine, gradable depth indicator. But the most important honest point in this lesson is this: frosting and shedding are endpoint indicators for some peels — they are not a measure of efficacy. Many effective superficial and metabolic peels never frost and produce little visible shedding while still resurfacing and improving pigment.

Erythema: the universal first signal

Erythema — pink-to-red flushing — appears with virtually every peel and reflects the inflammatory/vascular response to acid contact. It is a gradient, and you read its evolution:

  • Even, light-to-bright erythema is the expected endpoint for most superficial AHA and salicylic peels. It is your cue that the agent has engaged.
  • Speckled erythema progressing to streaky greying or blanching warns that you are approaching coagulation/frost — stop or neutralise before it consolidates if you intend a superficial peel.
  • Dusky, slow-to-blanch erythema suggests you have gone deeper than a superficial peel — relevant when you did not intend to.

In darker skin, erythema is subtler and harder to read against baseline pigment — a reason to err toward stopping early and to rely on time and protocol rather than colour alone.

Frosting: levels I–III (for coagulant peels)

Frost is the white discolouration produced when a coagulant agent (classically TCA) denatures protein. It is the cleanest live depth readout we have, and it is conventionally graded:

Frost levelAppearanceApprox. depth reached
Level ILight, speckled/transparent frost with erythema showing throughEpidermis / superficial
Level IIWhite-coated frost with pink/erythema still visible underneathFull epidermis to papillary dermis (medium)
Level IIISolid, opaque white frost with no underlying erythema (enamel-white)Reticular dermis (deep) — high-risk

The clinical use is direct: decide your target depth before you start, then stop adding coats the moment the corresponding frost level appears. Solid Level III frost is a deep-peel endpoint and a warning sign in any patient you did not select for a deep peel — and especially in Fitzpatrick IV–VI.

Pseudofrost and other look-alikes

Not every white film is coagulation frost, and misreading this leads to under- or over-treatment:

  • Salicylic pseudofrost: salicylic acid leaves a fine white powdery film as the acid precipitates on the skin as the vehicle evaporates. This is not protein denaturation and does not indicate depth — wiping it reveals it is surface deposit, not coagulated tissue.
  • Glycolic / AHA endpoints: metabolic AHA peels typically show erythema only and frequently no frost at all. Their endpoint is judged by erythema and elapsed time, and they are stopped by neutralisation, not by waiting for a colour change that may never come.

When to stop and neutralise

The endpoint dictates the action, and it differs by agent:

  1. Set the target before you begin
    Decide the intended depth and the matching endpoint (e.g. even erythema for a superficial AHA; Level I–II frost for a medium TCA).
  2. Read continuously, in good light
    Watch erythema and frost evolve coat by coat; in darker skin lean on protocol time as much as colour.
  3. Stop at the intended endpoint, not beyond
    For TCA, stop adding coats at the target frost level. For metabolic AHAs, neutralise at the planned time or at the first sign of confluent erythema.
  4. Neutralise where required
    Glycolic and other AHA peels require active neutralisation (bicarbonate/water). TCA is largely self-limiting; salicylic self-neutralises as it precipitates.

The honest-expectations point

Patients (and inexperienced operators) equate visible peeling with a peel "working." It is the opposite that is true: a gentle, frost-free, low-shed protocol can deliver excellent tone and pigment improvement, while a dramatic, deeply frosted peel in the wrong patient buys downtime and PIH, not better outcomes. The endpoint tells you the depth you reached — it does not grade the result. This is the message to set with every patient before the first session, and to weave into consent: results come from a correctly chosen depth applied across a sensible series, not from how much the skin visibly sheds afterward.

Key takeaway

Read erythema on every peel; grade frost (I–III) on coagulant peels as a live depth gauge; never mistake pseudofrost for coagulation; and never tell a patient — or yourself — that more frost or more shedding means a better result. The endpoint is a control instrument, not a scorecard.

Frequently asked questions

Does a peel have to frost to be effective?

No. Frosting is a depth indicator specific to coagulant peels such as TCA. Most superficial and metabolic (AHA) peels never frost and are still effective; their endpoint is erythema and elapsed time, and they are stopped by neutralisation.

What is the difference between frost and pseudofrost?

Frost is white discolouration from a coagulant agent denaturing skin protein, and it correlates with depth. Pseudofrost is the white film salicylic acid leaves as it precipitates on the surface as the vehicle dries — it is surface deposit, not coagulated tissue, and does not indicate depth.

What does Level III frosting mean?

Solid, opaque enamel-white frost with no underlying erythema indicates a deep (reticular-dermis) endpoint. It is intended only in carefully selected deep-peel patients and is a warning sign in anyone else — particularly in Fitzpatrick IV–VI, where it signals high PIH and scarring risk.

References

  1. Soleymani T, Lanoue J, Rahman Z. A Practical Approach to Chemical Peels (endpoints and frosting). J Clin Aesthet Dermatol. 2018;11(8):21–28.
  2. DermNet — Chemical peel (clinical endpoints and reactions).